Targeting the kappa opioid receptor for analgesia and antitumour effects
British Journal of Anaesthesia · 2025
DOI: 10.1016/j.bja.2024.10.014 ↗Kurz gefasst
Editorial in der Zeitschrift British Journal of Anaesthesia, 2025. Verfasst von David G Lambert und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Sciences, Anaesthesia, Critical Care and Pain Management, University of Leicester, Hodgkin Building, Leicester, UK. Hauptthemen laut MEDLINE: Analgesia, Analgesics, Opioid, Antineoplastic Agents, Glioma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Cancer Institute, National Institutes of Health, Memorial Sloan Kettering Cancer Center.
Abstract (Originalsprache)
Kappa opioid (KOP) receptor agonists have analgesic actions in a range of models, but central side-effects can limit their utility. In addition, non-analgesic actions of opioid receptors are receiving significant research interest. A recent article reports that high KOP receptor expression in glioma tissue correlates with improved survival and that KOP receptor agonism further promotes apoptosis of glioma cells through regulation of the p38 MAPK oncogenic pathway. This suggests that KOP receptor ligands could be developed as chemotherapeutic adjuncts in addition to their use as analgesics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Sciences, Anaesthesia, Critical Care and Pain Management, University of Leicester, Hodgkin Building, Leicester, UK.
- Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Anesthesiology, Weill Cornell Medicine, New York, NY, USA. Electronic address: mincerj@ms…
Förderung
- National Cancer Institute
- National Institutes of Health
- Memorial Sloan Kettering Cancer Center
Zitieren
APA
Lambert, D. G., & Mincer, J. S. (2025). Targeting the kappa opioid receptor for analgesia and antitumour effects. British Journal of Anaesthesia. https://doi.org/10.1016/j.bja.2024.10.014
Vancouver
Lambert DG, Mincer JS. Targeting the kappa opioid receptor for analgesia and antitumour effects. British Journal of Anaesthesia. 2025. doi:10.1016/j.bja.2024.10.014
BibTeX
@article{Lambert2025,
author = {Lambert, David G and Mincer, Joshua S},
title = {Targeting the kappa opioid receptor for analgesia and antitumour effects},
journal = {British Journal of Anaesthesia},
year = {2025},
doi = {10.1016/j.bja.2024.10.014}
}
EUVIMED